Aspirin; butalbital - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for aspirin; butalbital and what is the scope of patent protection?
Aspirin; butalbital
is the generic ingredient in six branded drugs marketed by Savage Labs, Lgm Pharma, Nostrum Labs Inc, Watson Labs, Allergan, Sandoz, Actavis Elizabeth, Fosun Pharma, Halsey, Hikma Intl Pharms, Ivax Pharms, Puracap Pharm, Quantum Pharmics, Strides Pharma, Lannett, Dr Reddys Labs Sa, and Stevens J, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.Summary for aspirin; butalbital
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 17 |
NDAs: | 22 |
Clinical Trials: | 1 |
DailyMed Link: | aspirin; butalbital at DailyMed |
Recent Clinical Trials for aspirin; butalbital
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
US Patents and Regulatory Information for aspirin; butalbital
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | BUTALBITAL, ASPIRIN AND CAFFEINE | aspirin; butalbital; caffeine | TABLET;ORAL | 204195-001 | Sep 22, 2016 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lgm Pharma | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | aspirin; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 075231-001 | Nov 30, 2001 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Ivax Pharms | BUTALBITAL, ASPIRIN AND CAFFEINE | aspirin; butalbital; caffeine | TABLET;ORAL | 085441-002 | Oct 31, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |